Hypertonic Saline Therapy in Ambulatory Heart Failure Unit.

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 167 participants.

Also called NCT04533997

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 167 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04533997
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Spain (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04533997. Randomized; quadruple masking; primary purpose treatment. Start 2021-01-01 (actual); primary completion 2023-05-10 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Hypertonic Saline Therapy in Ambulatory Heart Failure Unit.
Condition
Heart Failure
Intervention (Drug)
Hypertonic saline solution plus intravenous furosemide
Intervention (Drug)
Intravenous furosemide
Lead sponsor
Puerta de Hierro University Hospital (class: other)
Collaborator
Instituto de Salud Carlos III (class: other government)
Collaborator
Spanish Society of Cardiology (class: other)

Record details

Record id
cardio:ct-nct04533997
Content hash
a9e32f690cfe3695de08286dd26ba14ed401219f67c95399a5df620395ef62a1